1. Introduction to Device-Based treatments in Neuropsychiatric Disorders 2. The developing brain - relevance to pediatric neurotechnology 3. Neuropathophysiology of Pediatric Neuropsychiatric Disorders 4. Ethics of Device Based Treatments in Pediatric Neuropsychiatric Disorders 5. TMS in Autism Spectrum Disorder 6. Transcranial Magnetic Stimulation in Attention Deficit Hyperactivity Disorder 7. TMS in child/adolescent major depression 8. TMS in Tourette Syndrome and OCD 9. tDCS in Pediatric Neuropsychiatric Disorders 10. Deep Brain Stimulation for Pediatric Neuropsychiatric Disorders 11. Neurofeedback for neurodevelopmental disorders 12. Neurofeedback for emotion regulation 13. Chronotherapy for child/adolescent major depression 14. Conclusions and Future Directions for the field of Device-Based treatments in Neuropsychiatric Disorders
Dr. Lindsay Oberman is the Clinical Program Leader for the Center for Neuroscience and Regenerative Medicine, Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland. Dr. Oberman's research interest lies in using electrophysiological techniques (such as EEG and TMS and tDCS) to investigate and modulate neural circuits whose dysfunction may account for the behavioral pathology seen in autism spectrum disorder with the long-term goal of developing novel therapeutic interventions. She is an internationally recognized expert in the use of noninvasive brain stimulation in neurodevelopmental disorders having authored over 20 peer-reviewed papers on the topic.
Dr. Enticott is a Professor of Psychology (Cognitive Neuroscience) and Director of the Cognitive Neuroscience Unit (CNU) in the School of Psychology, at Deakin University (Melbourne, Australia). Dr. Enticott's work examines the neurobiological basis of social brain development and autism spectrum disorder (ASD) using a combination of neuroscience techniques (e.g., functional neuroimaging, electroencephalography, non-invasive brain stimulation). Dr. Enticott also conducts clinical trials assessing whether non-invasive brain stimulation (TMS, tDCS) can be used to improve both clinical and neurobiological aspects of ASD.